Why Choose the Evidence MultiSTAT?
Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated analyser that enables the detection of up to 48 targets simultaneously from a single patient sample. With minimal sample preparation required, results for 2 samples can be achieved in under 30 minutes allowing for quicker clinical decisions and timely patient management. Simply prepare the sample and add to the cartridge, load the reagent and tip cartridge to the MultiSTAT and press play. The pre-filled reagent cartridges and simple interface mean that with minimal laboratory training, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.
With a variety of panels available, the Evidence MultiSTAT tests for multiple markers, facilitating comprehensive screening.
MultiSTAT Clinical Panels
Biochip Array Technology
Biochip Array Technology enables rapid and precise detection of multiple analytes from a single patient sample.
The biochip is a solid-state device with discrete testing regions onto which antibodies specific to different analytes are immobilised and stabilised. Competitive or sandwich chemiluminescent immunoassays are then employed, offering a highly sensitive screen.
![Clinical MultiSTAT_Biochip Explained Clinical MultiSTAT_Biochip Explained](https://www.randox.com/wp-content/uploads/2024/03/Clinical-MultiSTAT_Biochip-Explained-560x310.png)
Evidence MultiSTAT Clinical Biochip Test Menu
Biochip Markers | |||
Clusterin | IL12p70 | IL13 | Midkine |
Biochip Markers | |||
EGF | IL-8 | MCP-1 | tPSA |
Biochip Markers | |||
IL-1β | IL-6 | PIINP | TNF-α |
Biochip Markers | |||
Estradiol | FSH | LH | Progesterone |
Prolactin | SHBG | Testosterone |